Outcomes and User Acceptance of the IntelliVue Alarm Advisor Software (Europe)

This Clinical Study will be conducted as a comparative study focusing on usability and efficiency by comparing alarm burden pre- and post-implementation of an "Alarm Advisor software".

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Clinical Alarms Alert Fatigue, Health Personnel Behavior Behavioral Symptoms Fatigue Mental Fatigue Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Klinikum Konstanz

Konstanz, Baden-Wurttemberg, 78464, Germany

About this study

In a first phase of data collection (pre-implementation) all alarms of an intensive care unit population are recorded.

In an interim period an Alarm Advisor software will be introduced to the unit.

In a second phase (post-implementation) the same set of alarm data will be recorded.

The "Alarm Advisor" Software can identify alarms based on criteria set by the medical staff and provide hints to reduce alarms and alarm nuisance (e.g. by proposing adjustments of alarm limits).

The effect of reduction of recurring nuisance alarms through the implementation of the Alarm Advisor shall be evaluated.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients admitted to the intensive care unit during the study period

Exclusion criteria

none

Treatment and study plan

Alarm Advisor

Other

Providing advice on alarm limits as part of routine medical care

Primary outcomes

Clinical Alarms

Time frame: six to eight months

Number of Different Alarms on Intensive Care

Sponsors and collaborators

Lead sponsor

Philips Healthcare

Industry

Registry information

Important dates

Study start: 2017
Primary completion: 2018
Study completion: 2018
First posted: Jun 9, 2017
Registry last updated: Apr 9, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed